장수 및 항노화 요법 시장 : 기회 및 전략(-2035년)

Longevity and anti-senescence therapy encompasses medical, biological, and technological interventions aimed at slowing, preventing, or reversing cellular aging (senescence) to extend healthy lifespan. These therapies include senolytics (drugs that remove senescent cells), senomorphics (agents that modify harmful cell behavior), regenerative medicine, gene therapies, metabolic interventions, and advanced diagnostics that target aging pathways. The primary purpose of longevity and anti-senescence therapy is to improve healthspan, delay age-related diseases, and enhance overall physiological function.

The longevity and anti-senescence therapy market consists of sales, by entities (organizations, sole traders, or partnerships), of longevity and anti-senescence therapy intended to delay aging, restore cellular function and improve long term physiological health. These therapies are used by adults seeking preventive health, vitality, cognitive support and reduced age-related deterioration. They are adopted in clinical settings, wellness clinics, research centers, home based protocols and specialized longevity programs. Users include health-conscious individuals, older adults, athletes and people seeking to optimize long term biological performance.

The global longevity and anti-senescence therapy market was valued at $22,235.1 million in 2020 which grew till 2025 at a compound annual growth rate (CAGR) of more than 6.00%.

Increase In Demand For Medical Tourism

During the historic period, the longevity and anti-senescence therapy market was driven by the increase in demand for medical tourism. Medical travelers often seek specialized treatments, rejuvenation therapies and advanced wellness procedures that are either more affordable or more accessible abroad, making longevity-focused services an attractive part of international healthcare packages. Moreover, government-led initiatives and quality-assurance programs have strengthened trust in medical tourism destinations, enabling growth in foreign patient inflows for both curative and preventive health services. For instance, in August 2025, India's Ministry of Tourism, through the Press Information Bureau (PIB), the central agency of the Government of India responsible for disseminating official information and statistical data, reported detailed statistics on foreign tourist arrivals (FTAs) for medical purposes, highlighting a steady rise in medical-value travel over recent years. The total FTAs for medical purposes increased from 182,945 to 644,387 across successive years, reflecting sustained international demand. Additionally, India recorded 131,856 medical tourists up to April 2025, accounting for approximately 4.1% of total FTAs during this period. Therefore, the longevity and anti-senescence therapy market was driven by the increase in demand for medical tourism.

Integration Of Senolytic Immunotherapies To Address Age-Linked Cancer Progression

Major companies in the longevity and anti-senescence therapy market are focusing on the integration of senolytic immunotherapies designed to target and eliminate senescent cells that contribute to disease progression, particularly in age-associated cancers. These innovations emphasize enhancing immune recognition, improving therapeutic precision and offering next-generation treatment formats that overcome the limitations of conventional anti-cancer approaches. For instance, in July 2024, Immorta Bio, Inc., a US-based longevity biotechnology company specializing in senolytic and cell-rejuvenation therapies, filed an Investigational New Drug (IND) application for SenoVax, a first-in-class senolytic immunotherapy developed for the treatment of advanced non-small cell lung cancer. The therapy is designed to address typical challenges associated with standard cancer treatments by using autologous dendritic cells to stimulate targeted clearance of senescent cells within the tumor environment, thereby improving immune responsiveness and potentially slowing disease progression. These capabilities offer a more specialized and durable therapeutic option for patients who have exhausted conventional treatments. By utilizing advanced immune-modulation technology and personalized cell-based platforms, the company aims to develop therapies that target senescent cell burden, enhance treatment outcomes and meet the evolving medical needs of both domestic and global longevity and oncology markets.

The global longevity and anti-senescence therapy market is highly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 1.69% of the total market in 2024.

Longevity And Anti-Senescence Therapy Global Market Opportunities And Strategies To 2035 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global longevity and anti-senescence therapy market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for longevity and anti-senescence therapy? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The longevity and anti-senescence therapy market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider longevity and anti-senescence therapy market; and compares it with other markets.

The report covers the following chapters

• Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by therapy, by applications, and by end user.
• Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Growth Analysis And Strategic Analysis Framework Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
• Global Market Size And Growth Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
• Regional And Country Analysis- Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
• Market Segmentation- Contains the market values (2019-2024) (2024-2029, 2034F) and analysis for each segment by therapy, by applications, and by end user in the market. Historic (2019-2024) and forecast (2024-2029) and (2029-2034) market values and growth and market share comparison by region market.
• Regional Market Size and Growth- Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Other Major And Innovative Companies Details on the company profiles of other major and innovative companies in the market.
• Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
• Competitive Dashboard- Briefs on competitive dashboard of major players.
• Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
• Recent Developments Information on recent developments in the market covered in the report.
• Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations- This section includes recommendations for Longevity and anti-senescence therapy providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

• 1) By Therapy: Senolytic Drug Therapy; Gene Therapy; Cell Therapy; Mitochondrial Therapy; Immunotherapy; Other Therapies
• 2) By Application: Longevity; Senescence Inhibition; Cardiovascular Diseases; Neural Degenerative Diseases; Ophthalmology Disorders; Cancer
• 3) By End Users: Hospital; Medical Service Institution
• Companies Mentioned: Life Extension; BioTE Medical LLC; Thorne HealthTech; Beike Biotechnology; Jarrow Formulas
• Countries: China; India; USA; South Korea; Japan; Brazil; Indonesia; Germany; UK; Russia; France; Italy; Canada; Spain; Australia
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time-series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; longevity and anti-senescence therapy indicators comparison.
• Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

• 1.1 Longevity And Anti-Senescence Therapy - Market Attractiveness And Macro Economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

• 6.1 General Market Definition
• 6.2 Summary
• 6.3 Longevity And Anti-Senescence Therapy Market Definition And Segmentations
• 6.4 Market Segmentation By Therapy
  • 6.4.1 Senolytic Drug Therapy
  • 6.4.2 Gene Therapy
  • 6.4.3 Cell Therapy
  • 6.4.4 Mitochondrial Therapy
  • 6.4.5 Immunotherapy
  • 6.4.6 Other Therapies
• 6.5 Market Segmentation By Application
  • 6.5.1 Longevity
  • 6.5.2 Senescence Inhibition
  • 6.5.3 Cardiovascular Diseases
  • 6.5.4 Neural Degenerative Diseases
  • 6.5.5 Ophthalmology Disorders
  • 6.5.6 Cancer
• 6.6 Market Segmentation By End User
  • 6.6.1 Hospital
  • 6.6.2 Medical Service Institution

7 Major Market Trends

• 7.1 Integration Of Senolytic Immunotherapies To Address Age-Linked Cancer Progression
• 7.2 Development Of Regenerative Stem-Cell Therapies To Address Age-Related Organ Failure
• 7.3 Introduction Of AI-Enabled Platforms To Identify Novel Senolytic Drug Candidates
• 7.4 Launch Of Advanced Anti-Aging Nutraceuticals Using Multi-Pathway Formulations

8 Global Longevity And Anti-Senescence Therapy Growth Analysis And Strategic Analysis Framework

• 8.1 Global Longevity And Anti-Senescence Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors)
  • 8.1.1 Political
  • 8.1.2 Economic
  • 8.1.3 Social
  • 8.1.4 Technological
  • 8.1.5 Environmental
  • 8.1.6 Legal
• 8.2 Analysis Of End User (B2B)
  • 8.2.1 Hospital
  • 8.2.2 Medical Service Institution
• 8.3 Global Longevity And Anti-Senescence Therapy Market Growth Rate Analysis
• 8.4 Historic Market Growth, 2020 - 2025, Value ($ Million)
  • 8.4.1 Market Drivers 2020 - 2025
  • 8.4.2 Market Restraints 2020 - 2025
• 8.5 Forecast Market Growth, 2025 - 2030, 2035F Value ($ Million)
• 8.6 Forecast Growth Contributors/Factors
  • 8.6.1 Quantitative Growth Contributors
  • 8.6.2 Drivers
  • 8.6.3 Restraints
• 8.7 Global Longevity And Anti-Senescence Therapy Total Addressable Market (TAM)
  • 8.7.1 TAM Comparison Analysis

9 Global Longevity And Anti-Senescence Therapy Market Segmentation

• 9.1 Global Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.2 Global Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.3 Global Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.4 Global Longevity And Anti-Senescence Therapy Market, Sub-Segmentation Of Senolytic Drug Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.5 Global Longevity And Anti-Senescence Therapy Market, Sub-Segmentation Of Gene Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.6 Global Longevity And Anti-Senescence Therapy Market, Sub-Segmentation Of Cell Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.7 Global Longevity And Anti-Senescence Therapy Market, Sub-Segmentation Of Mitochondrial Therapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.8 Global Longevity And Anti-Senescence Therapy Market, Sub-Segmentation Of Immunotherapy, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 9.9 Global Longevity And Anti-Senescence Therapy Market, Sub-Segmentation Of Other Therapies, By Type, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

10 Longevity And Anti-Senescence Therapy Market, Regional and Country Analysis

• 10.1 Global Longevity And Anti-Senescence Therapy Market, By Region, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 10.2 Global Longevity And Anti-Senescence Therapy Market, By Country, Historic and Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

11 Asia-Pacific Market

• 11.1 Summary
• 11.2 Market Overview
  • 11.2.1 Region Information
  • 11.2.2 Market Information
  • 11.2.3 Background Information
  • 11.2.4 Government Initiatives
  • 11.2.5 Regulations
  • 11.2.6 Regulatory Bodies
  • 11.2.7 Major Associations
  • 11.2.8 Taxes Levied
  • 11.2.9 Corporate Tax Structure
  • 11.2.10 Investments
  • 11.2.11 Major Companies
• 11.3 Asia-Pacific Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.4 Asia-Pacific Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.5 Asia-Pacific Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.6 China Market
• 11.7 Summary
• 11.8 Market Overview
  • 11.8.1 Country Information
  • 11.8.2 Market Information
  • 11.8.3 Background Information
  • 11.8.4 Government Initiatives
  • 11.8.5 Regulations
  • 11.8.6 Regulatory Bodies
  • 11.8.7 Major Associations
  • 11.8.8 Taxes Levied
  • 11.8.9 Corporate Tax Structure
  • 11.8.10 Major Companies
• 11.9 China Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.10 China Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.11 China Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.12 India Market
• 11.13 India Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.14 India Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.15 India Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.16 Japan Market
• 11.17 Summary
• 11.18 Market Overview
  • 11.18.1 Country Information
  • 11.18.2 Market Information
  • 11.18.3 Background Information
  • 11.18.4 Government Initiatives
  • 11.18.5 Regulations
  • 11.18.6 Regulatory Bodies
  • 11.18.7 Major Associations
  • 11.18.8 Taxes Levied
  • 11.18.9 Corporate Tax Structure
  • 11.18.10 Major Companies
• 11.19 Japan Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.20 Japan Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.21 Japan Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.22 Australia Market
• 11.23 Australia Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.24 Australia Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.25 Australia Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.26 Indonesia Market
• 11.27 Indonesia Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.28 Indonesia Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.29 Indonesia Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.30 South Korea Market
• 11.31 Summary
• 11.32 Market Overview
  • 11.32.1 Country Information
  • 11.32.2 Market Information
  • 11.32.3 Background Information
  • 11.32.4 Government Initiatives
  • 11.32.5 Regulations
  • 11.32.6 Regulatory Bodies
  • 11.32.7 Major Associations
  • 11.32.8 Taxes Levied
  • 11.32.9 Corporate Tax Structure
  • 11.32.10 Major Companies
• 11.33 South Korea Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.34 South Korea Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 11.35 South Korea Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

12 Western Europe Market

• 12.1 Summary
• 12.2 Market Overview
  • 12.2.1 Region Information
  • 12.2.2 Market Information
  • 12.2.3 Background Information
  • 12.2.4 Government Initiatives
  • 12.2.5 Regulations
  • 12.2.6 Regulatory Bodies
  • 12.2.7 Major Associations
  • 12.2.8 Taxes Levied
  • 12.2.9 Corporate tax structure
  • 12.2.10 Major Companies
• 12.3 Western Europe Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.4 Western Europe Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.5 Western Europe Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.6 Western Europe Longevity And Anti-Senescence Therapy Market: Country Analysis
• 12.7 UK Market
• 12.8 UK Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.9 UK Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.10 UK Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.11 Germany Market
• 12.12 Germany Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.13 Germany Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.14 Germany Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.15 France Market
• 12.16 France Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.17 France Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.18 France Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.19 Italy Market
• 12.20 Italy Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.21 Italy Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.22 Italy Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.23 Spain Market
• 12.24 Spain Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.25 Spain Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 12.26 Spain Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

13 Eastern Europe Market

• 13.1 Summary
• 13.2 Market Overview
  • 13.2.1 Region Information
  • 13.2.2 Market Information
  • 13.2.3 Background Information
  • 13.2.4 Government Initiatives
  • 13.2.5 Regulations
  • 13.2.6 Regulatory Bodies
  • 13.2.7 Major Associations
  • 13.2.8 Taxes Levied
  • 13.2.9 Corporate Tax Structure
  • 13.2.10 Investment
  • 13.2.11 Major companies
• 13.3 Eastern Europe Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.4 Eastern Europe Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.5 Eastern Europe Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.6 Eastern Europe Longevity And Anti-Senescence Therapy Market: Country Analysis
• 13.7 Russia Market
• 13.8 Russia Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.9 Russia Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 13.10 Russia Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

14 North America Market

• 14.1 Summary
• 14.2 Market Overview
  • 14.2.1 Region Information
  • 14.2.2 Market Information
  • 14.2.3 Background Information
  • 14.2.4 Government Initiatives
  • 14.2.5 Regulations
  • 14.2.6 Regulatory Bodies
  • 14.2.7 Major Associations
  • 14.2.8 Taxes Levied
  • 14.2.9 Corporate Tax Structure
  • 14.2.10 Investments
  • 14.2.11 Major Companies
• 14.3 North America Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.4 North America Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.5 North America Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.6 North America Longevity And Anti-Senescence Therapy Market: Country Analysis
• 14.7 USA Market
• 14.8 Summary
• 14.9 Market Overview
  • 14.9.1 Country Information
  • 14.9.2 Market Information
  • 14.9.3 Background Information
  • 14.9.4 Government Initiatives
  • 14.9.5 Regulations
  • 14.9.6 Regulatory Bodies
  • 14.9.7 Major Associations
  • 14.9.8 Taxes Levied
  • 14.9.9 Corporate Tax Structure
  • 14.9.10 Investments
  • 14.9.11 Major Companies
• 14.10 USA Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.11 USA Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.12 USA Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.13 Canada Market
• 14.14 Summary
• 14.15 Market Overview
  • 14.15.1 Country Information
  • 14.15.2 Market Information
  • 14.15.3 Background Information
  • 14.15.4 Government Initiatives
  • 14.15.5 Regulations
  • 14.15.6 Regulatory Bodies
  • 14.15.7 Major Associations
  • 14.15.8 Taxes Levied
  • 14.15.9 Corporate Tax Structure
  • 14.15.10 Investments
  • 14.15.11 Major Companies
• 14.16 Canada Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.17 Canada Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 14.18 Canada Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

15 South America Market

• 15.1 Summary
• 15.2 Market Overview
  • 15.2.1 Region Information
  • 15.2.2 Market Information
  • 15.2.3 Background Information
  • 15.2.4 Government Initiatives
  • 15.2.5 Regulations
  • 15.2.6 Regulatory Bodies
  • 15.2.7 Major Associations
  • 15.2.8 Taxes Levied
  • 15.2.9 Corporate Tax Structure
  • 15.2.10 Major Companies
• 15.3 South America Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.4 South America Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.5 South America Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.6 South America Longevity And Anti-Senescence Therapy Market: Country Analysis
• 15.7 Brazil Market
• 15.8 Brazil Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.9 Brazil Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 15.10 Brazil Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

16 Middle East Market

• 16.1 Summary
• 16.2 Market Overview
  • 16.2.1 Region Information
  • 16.2.2 Market Information
  • 16.2.3 Background Information
  • 16.2.4 Government Initiatives
  • 16.2.5 Regulations
  • 16.2.6 Regulatory Bodies
  • 16.2.7 Major Associations
  • 16.2.8 Taxes Levied
  • 16.2.9 Corporate Tax Structure
  • 16.2.10 Major Companies
• 16.3 Middle East Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.4 Middle East Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 16.5 Middle East Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

17 Africa Market

• 17.1 Summary
• 17.2 Market Overview
  • 17.2.1 Region Information
  • 17.2.2 Market Information
  • 17.2.3 Background Information
  • 17.2.4 Government Initiatives
  • 17.2.5 Regulations
  • 17.2.6 Regulatory Bodies
  • 17.2.7 Major Associations
  • 17.2.8 Taxes Levied
  • 17.2.9 Corporate Tax Structure
  • 17.2.10 Major Companies
• 17.3 Africa Longevity And Anti-Senescence Therapy Market, Segmentation By Therapy, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.4 Africa Longevity And Anti-Senescence Therapy Market, Segmentation By Application, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)
• 17.5 Africa Longevity And Anti-Senescence Therapy Market, Segmentation By End User, Historic And Forecast, 2020 - 2025, 2030F, 2035F, Value ($ Million)

18 Competitive Landscape And Company Profiles

• 18.1 Company Profiles
• 18.2 Life Extension
  • 18.2.1 Company Overview
  • 18.2.2 Products And Services
  • 18.2.3 Financial Overview
• 18.3 BioTE Medical LLC
  • 18.3.1 Company Overview
  • 18.3.2 Products And Services
  • 18.3.3 Financial Overview
• 18.4 Thorne HealthTech
  • 18.4.1 Company Overview
  • 18.4.2 Products And Services
  • 18.4.3 Business Strategy
  • 18.4.4 Financial Overview
• 18.5 Beike Biotechnology
  • 18.5.1 Company Overview
  • 18.5.2 Products And Services
  • 18.5.3 Financial Overview
• 18.6 Jarrow Formulas
  • 18.6.1 Company Overview
  • 18.6.2 Products And Services
  • 18.6.3 Business Strategy
  • 18.6.4 Financial Overview

19 Other Major And Innovative Companies

• 19.1 ChromaDex Inc.
  • 19.1.1 Company Overview
  • 19.1.2 Products And Services
• 19.2 Defy Medical LLC.
  • 19.2.1 Company Overview
  • 19.2.2 Products And Services
• 19.3 Cenegenics LLC.
  • 19.3.1 Company Overview
  • 19.3.2 Products And Services
• 19.4 Doctor's Best
  • 19.4.1 Company Overview
  • 19.4.2 Products And Services
• 19.5 Elysium Health Inc.
  • 19.5.1 Company Overview
  • 19.5.2 Products And Services
• 19.6 Regenexx
  • 19.6.1 Company Overview
  • 19.6.2 Products And Services
• 19.7 Timeline (Formerly Amazentis SA) (Mitopure)
  • 19.7.1 Company Overview
  • 19.7.2 Products And Services
• 19.8 SottoPelle Inc.
  • 19.8.1 Company Overview
  • 19.8.2 Products And Services
• 19.9 HealthGAINS
  • 19.9.1 Company Overview
  • 19.9.2 Products And Services
• 19.10 Celltex Therapeutics Corporation
  • 19.10.1 Company Overview
  • 19.10.2 Products And Services
• 19.11 Double Wood Supplements
  • 19.11.1 Company Overview
  • 19.11.2 Products And Services
• 19.12 Longevinex
  • 19.12.1 Company Overview
  • 19.12.2 Products And Services
• 19.13 R3 Stem Cell
  • 19.13.1 Company Overview
  • 19.13.2 Products And Services
• 19.14 GIOSTAR Mexico
  • 19.14.1 Company Overview
  • 19.14.2 Products And Services
• 19.15 StemWell
  • 19.15.1 Company Overview
  • 19.15.2 Products And Services

20 Competitive Dashboard

21 Key Mergers And Acquisitions

• 21.1 Granata Bio Acquired Oviva Therapeutics

22 Recent Developments In Longevity And Anti-Senescence Therapy

• 22.1 Development Of Comprehensive Longevity Supplements Targeting Multiple Hallmarks Of Aging
• 22.2 Development Of Multi-Ingredient NMN Supplements To Enhance Cellular Longevity Support

23 Opportunities And Strategies

• 23.1 Global Longevity And Anti-Senescence Therapy Market In 2030 - Countries Offering Most New Opportunities
• 23.2 Global Longevity And Anti-Senescence Therapy Market In 2030 - Segments Offering Most New Opportunities
• 23.3 Global Longevity And Anti-Senescence Therapy Market In 2030 - Growth Strategies
  • 23.3.1 Market Trend Based Strategies
  • 23.3.2 Competitor Strategies

24 Longevity And Anti-Senescence Therapy Market, Conclusions And Recommendations

• 24.1 Conclusions
• 24.2 Recommendations
  • 24.2.1 Product
  • 24.2.2 Place
  • 24.2.3 Price
  • 24.2.4 Promotion
  • 24.2.5 People

25 Appendix

• 25.1 Geographies Covered
• 25.2 Market Data Sources
• 25.3 Research Methodology
• 25.4 Currencies
• 25.5 The Business Research Company
• 25.6 Copyright and Disclaimer